Underrepresentation of Asian Americans, Native Hawaiians, and other Pacific Islanders (AA & NHPI) in cancer clinical trials that led to FDA approvals in 2010-2022.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback